Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("
"); });
2021-06-02 HKT 00:38
Share this story
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity
Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more
BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom
BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more
Webinar: When Account Takeover Moves Past Onboarding
Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more
JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson
JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more
Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term
The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more
Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal
Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more